Acciones M Pharmaceutical Inc Deutsche Boerse AG
Acciones
CA55346E2050
Biotecnología e investigación médica
Ventas 2018 | 0,75 0,69 | Ventas 2019 | 0,71 0,65 | Capitalización | 3,53 M 3,24 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -5 M -4,6 M | Resultado Neto 2019 | -1 M -920 mil | VE / Ventas 2018 | 4.852.616 x |
Deuda neta 2018 | 319 mil 293 mil | Deuda neta 2019 | 848 mil 780 mil | VE / Ventas 2019 | 6.168.166 x |
P/E ratio 2018 |
-0,6
x | P/E ratio 2019 |
-1,97
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 72,04 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | - | 03/01/18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01/12/14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
+29,77 % | 49,46 mil M | |
+1,00 % | 42,58 mil M | |
+50,24 % | 42,49 mil M | |
-5,26 % | 29,09 mil M | |
+13,68 % | 26,61 mil M | |
-22,99 % | 18,64 mil M | |
+8,22 % | 13,16 mil M | |
+32,41 % | 12,55 mil M | |
+24,01 % | 12,1 mil M |